Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1697408

registered interest
date	20/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of when data will be placed into the federated data platform for NHS trusts and integrated care systems.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	19562
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>The Federated Data Platform will allow the National Health Service to make better use of data to improve outcomes for patients, including reducing waits and discharging people quicker from hospital.</p><p>45 organisations who participated in the NHS England pilot, broken down into 42 trusts, two integrated care boards, and the City Healthcare Partnership Community Interest Company, have begun to transition into the Federated Data Platform, in a sequence of waves scheduled between March and May 2024. NHS England aims for all trusts and integrated care boards who wish to use the platform to do so within the next three years.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/03/2024 13:22:20 answering member 4044 label Biography information for Andrew Stephenson previous answer version 25897 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1695397

registered interest
date	12/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ophthalmic Services: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when does she expect the photobiomodulation process for treatment of those with severe eye problems to be made available via the NHS.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	18070
answer	answer is ministerial correction date of answer 15/03/2024 answer text <p>Clinicians utilise the best available evidence, including guidance from The National Institute for Health and Care Excellence (NICE), to determine appropriate treatments to be made available to patients via the National Health Service.</p><p>The NICE runs an interventional procedures programme to assess the efficacy and safety of interventional procedures used for treatment or diagnosis, to determine whether they work well enough and are safe enough for use in the NHS. The programme can assess procedures that involve incision, puncture, and entry into a body cavity, or that use ionising, electromagnetic, or acoustic energy.</p><p>The NICE’s interventional procedures programme is not currently looking at this procedure in relation to the treatment of eye problems, and there has been no notification to the NICE for consideration of photobiomodulation for treatment of those with severe eye problems.</p><p>The Department is committed to partnering with industry, patients, and the wider health and social care system to ensure effective and innovative medical technologies that support the continued delivery of high-quality care and outstanding patient safety, are available to patients. Innovators can sign up to the NHS Innovation Service for guidance on the key steps to introduce their idea or product to the NHS.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/03/2024 16:48:40 answering member 4044 label Biography information for Andrew Stephenson previous answer version 23986 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1693272

registered interest
date	04/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her timetable is for the introduction of the recommendations of the final evaluation report for the secondary care routine reflux cohort of the Cytosponge test.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	16637
answer	answer is ministerial correction date of answer 07/03/2024 answer text <p>On 26 February 2024, NHS England published the results of the cytosponge test pilot for secondary care routine reflux and Barrett’s surveillance cohort, which began in January 2021, and launched at 30 hospitals across England. The pilot tested over 8,500 patients with the capsule sponge test. Evaluation of a cohort of patients showed almost eight out of 10 patients, who completed a test, were discharged without the need for further testing, freeing up endoscopy capacity for higher risk patients and those referred for urgent tests for oesophageal cancer. Patients with positive results from the capsule sponge test who were referred on for an endoscopy had the highest prevalence of Barrett’s oesophagus, at 27.2%, compared to zero patients with negative results who completed an endoscopy.</p><p>A timetable for the introduction of the recommendations of the final evaluation report for the secondary care routine reflux cohort of the cytosponge test, is yet to be finalised and published.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 07/03/2024 09:53:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1691422

registered interest
date	23/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cardiovascular Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 November 2023 to Question 1604 on Cardiovascular Diseases, what her planned timetable is to respond to the report from the Government Champion for Personalised Prevention's taskforce on cardiovascular disease.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	15416
answer	answer is ministerial correction date of answer 28/02/2024 answer text <p>The Government is considering the recommendations of the Government Champion for Personalised Prevention, and information on the next steps will be provided in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/02/2024 09:55:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1690797

registered interest
date	21/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the impact of the decision to lower the age for bowel cancer screening on levels of bowel cancer.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	15027
answer	answer is ministerial correction date of answer 26/02/2024 answer text <p>Evidence shows that screening people at a younger age would enable more bowel cancers to be picked up at an earlier stage, where treatment is likely to be more effective and survival chances improved. Based on the UK National Screening Committee’s (UK NSC) last review of the bowel cancer screening programme, since April 2021, the National Health Service in England has been gradually reducing the age for bowel screening from 60 years old down to 50 years old.</p><p> </p><p>Modelling work commissioned by the UK NSC at the time concluded that introducing the faecal immunochemical test (FIT) for home testing in the 50 to 74 year old age range, at as low a threshold as possible, would be the most cost effective approach. Work continues in this area to ensure that lowering the age of bowel cancer screening down to 50 years old is done with workforce planning and capacity. Further details of the evidence around screening at a younger age and the modelling work, is available at the following link:</p><p><a href="https://view-health-screening-recommendations.service.gov.uk/bowel-cancer/" target="_blank">https://view-health-screening-recommendations.service.gov.uk/bowel-cancer/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/02/2024 10:11:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1689857

registered interest
date	19/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the implications for her policies on the treatment of lobular breast cancer of the Institute of Cancer Research's Lobular Moonshot Project.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	14482
answer	answer is ministerial correction date of answer 22/02/2024 answer text <p>The Government is committed to supporting patient access to promising and innovative new treatments, including treatments for lobular breast cancer. Research is crucial in the fight against cancer, and in developing tailored treatments for lobular breast cancer specifically. That is why the Department invests in health and care research through the National Institute for Health and Care Research (NIHR), which had a research expenditure of over £121.8 million for all cancers for 2022/23.</p><p>The Lobular Moonshot Project is a high-level request for research fellowships and projects in lobular breast cancer, to be funded by the Institute of Cancer Research (ICR). In 2022 the NIHR awarded £29 million to the ICR and its partner, the Royal Marsden, through the NIHR Biomedical Research Centres competition. This award includes work on lobular breast cancer. The NIHR encourages research proposals in lobular breast cancer to compete for its health and care research funding. Applications are subject to peer review and judged in open competition with awards being made on the basis of value for money and scientific quality.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/02/2024 11:36:34 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1690038

registered interest
date	19/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lisdexamfetamine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure supplies of lisdexamfetamine capsules.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	14483
answer	answer is ministerial correction date of answer 22/02/2024 answer text <p>We are aware of the supply issues affecting medicines used for the management of attention deficit hyperactivity disorder (ADHD). This is a global issue and other markets are also affected. We can confirm that the intermittent supply disruptions affecting lisdexamfetamine capsules are expected to be largely resolved by April or May 2024.</p><p> </p><p>We have issued communications to the National Health Service to advise healthcare professionals on the management of patients whilst there continues to be disruption to supplies, including issuing a National Patient Safety Alert in September 2023 and a further Medicine Supply Notification in February 2024. We have also added ADHD products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom, to protect domestic supplies. We have also published a list of currently available and unavailable ADHD products on the NHS Specialist Pharmacy Service website, which is regularly updated to ensure that those involved in the prescribing and dispensing of medications can make informed decisions. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/02/2024 11:40:24 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1687368

registered interest
date	05/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Streptococcus: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she expects to receive the Group B Streptococcus cluster randomised trial results.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	12911
answer	answer is ministerial correction date of answer 08/02/2024 answer text <p>I refer the Hon. Member to the answer I gave on 15 January 2024 to Question <a href="https://questions-statements.parliament.uk/written-questions/detail/2024-01-10/8936" target="_blank">8936</a>.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/02/2024 10:09:18 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1683622

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Processed Food: Sugar
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will hold discussions with the food industry on reducing the sugar content in (a) food and (b) drink products.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	10596
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>As she has done in previous ministerial roles, the current Secretary of State will recuse herself on departmental issues relating to outside interests, all of which have been declared to the House and under the Ministerial Code.</p><p>Discussions have been held with businesses by the Minister for Public Health, and officials, since 2015, on the actions they can take to reduce the sugar content of food and drink products.</p><p>The Soft Drinks Industry Levy (SDIL) came in to force in April 2018. Between 2015 and 2020, levels of sugar in drinks subject to SDIL reduced by 46%, removing over 45,000 tonnes of sugar, while sales increased by approximately 21%. The reductions were spread evenly across all socio-economic groups.</p><p>Milk based drinks are excluded from the levy but are included in the voluntary sugar reduction programme. To date, sugar and calories in pre-packed milk based drinks sold through retail have reduced by 29.7% and 20%, respectively. Pre-packed milk substitute drinks have reduced sugar and calories by 6.9% and 8%, respectively.</p><p>The voluntary sugar reduction programme also includes the foods that contribute most to the sugar intakes of children aged up to 18 years old. Between 2015 and 2020, reductions in sugar levels were seen in all categories, with breakfast cereals and yogurts and fromage frais showing the greatest change with reductions of 14.9% and 13.5%, respectively, and removing 21,960 tonnes of sugar.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 24/01/2024 17:37:57 answering member 4117 label Biography information for Andrea Leadsom
tabling member	1409 label Biography information for Mr Gregory Campbell

1681771

registered interest
date	12/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	World Health Assembly
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the cost to her Department was for officials to attend the fourth meeting of the Working Group on Amendments to the International Health Regulations in July 2023.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	9335
answer	answer is ministerial correction date of answer 24/01/2024 answer text <p>The travel and accommodation costs for officials to attend was £980.15.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/01/2024 11:28:43 answering member 4044 label Biography information for Andrew Stephenson previous answer version 11978 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell